Italia

35 nuovi farmaci in commercio

Nuove specialitÓ medicinali:Depalgos, Enerzair Breezhaler, Hyrimoz, Innohep, Lyumjev, Netildex, Nubeqa, Piqray, Revestive, Suboxone, Trazimera, Vaborem.6 Nuovi farmaci equivalenti

Nuove specialità medicinali
DEPALGOS 28 cpr eff 10 mg + 325 mg ossicodone cloridrato/paracetamolo
MOLTENI AIC:035313156 15,30€ A/RNR in commercio dal:07/04/2021

DEPALGOS 28 cpr eff 20 mg + 325 mg ossicodone cloridrato/paracetamolo
MOLTENI AIC:035313182 15,30€ A/RNR in commercio dal:07/04/2021

DEPALGOS 28 cpr eff 5 mg + 325 mg ossicodone cloridrato/paracetamolo
MOLTENI AIC:035313129 15,30€ A/RNR in commercio dal:07/04/2021

ENERZAIR BREEZHALER polv inal 30 x 1 cps 114 mcg + 46 mcg + 136 mcg + inalatore indacaterolo acetato/glicopirronio bromuro/mometasone furoato
NOVARTIS AIC:048913026 89,12€ Cnn / RRL in commercio dal:09/04/2021

ENERZAIR BREEZHALER polv inal 30 x 1 cps 114 mcg + 46 mcg + 136 mcg + inalatore + 1 sensore indacaterolo acetato/glicopirronio bromuro/mometasone furoato
NOVARTIS AIC:048913038 89,12€ Cnn / RRL in commercio dal:09/04/2021

HYRIMOZ 2 siringhe preriempite SC 0,4 ml 20 mg con dispositivo di sicurezza dell'ago adalimumab
SANDOZ AIC:046889073 565,02€ H/RRL in commercio dal:30/03/2021

INNOHEP 10 siringhe 10.000 UI/0,5 ml tinzaparina sodica
LEO PHARMA A/S AIC:047494125 128,73€ A/RR in commercio dal:21/04/2021

INNOHEP 10 siringhe 12.000 UI/0,6 ml tinzaparina sodica
LEO PHARMA A/S AIC:047494188 139,42€ A/RR in commercio dal:21/04/2021

INNOHEP 10 siringhe 14.000 UI/0,7 ml tinzaparina sodica
LEO PHARMA A/S AIC:047494240 162,65€ A/RR in commercio dal:21/04/2021

INNOHEP 10 siringhe 16.000 UI/0,8 ml tinzaparina sodica
LEO PHARMA A/S AIC:047494303 185,89€ A/RR in commercio dal:21/04/2021

INNOHEP 10 siringhe 18.000 UI/0,9 ml tinzaparina sodica
LEO PHARMA A/S AIC:047494366 209,12€ A/RR in commercio dal:21/04/2021

INNOHEP 10 siringhe 2.500 UI/0,25 ml tinzaparina sodica
LEO PHARMA A/S AIC:047494075 29,04€ A/RR in commercio dal:21/04/2021

INNOHEP 10 siringhe 3.500 UI/0,35 ml tinzaparina sodica
LEO PHARMA A/S AIC:047494087 40,67€ A/RR in commercio dal:21/04/2021

INNOHEP 10 siringhe 4.500 UI/0,45 ml tinzaparina sodica
LEO PHARMA A/S AIC:047494099 52,28€ A/RR in commercio dal:21/04/2021

INNOHEP 10 siringhe 8.000 UI/0,4 ml tinzaparina sodica
LEO PHARMA A/S AIC:047494036 92,94€ A/RR in commercio dal:21/04/2021

LYUMJEV 1 flaconcino SC 1.000 UI 10 ml insulina lispro da dna ricombinante
ELI LILLY AIC:048613018 35,23€ Cnn / RR in commercio dal:09/04/2021

LYUMJEV JUNIOR KWIKPEN 5 penne preriempite SC 3 ml 100 U/ml insulina lispro da dna ricombinante
ELI LILLY AIC:048613119 52,91€ Cnn / RR in commercio dal:09/04/2021

LYUMJEV KWIKPEN 5 penne preriempite SC 3 ml 100 U/ml insulina lispro da dna ricombinante
ELI LILLY AIC:048613083 52,91€ Cnn / RR in commercio dal:09/04/2021

LYUMJEV KWIKPEN 5 penne preriempite SC 3 ml 200 U/ml insulina lispro da dna ricombinante
ELI LILLY AIC:048613145 105,81€ Cnn / RR in commercio dal:09/04/2021

NETILDEX collirio 30 monod 0,3 ml 3 mg/ml + 1 mg/ml desametasone fosfato disodico/netilmicina solfato
SIFI AIC:036452062 22,50€ Cnn / RR in commercio dal:06/04/2021

NUBEQA 112 cpr riv 300 mg darolutamide
BAYER AIC:048610012 5.351,83€ H/RNRL in commercio dal:29/03/2021

PIQRAY 28 cpr riv 200 mg alpelisib
NOVARTIS AIC:048918080 7149,53€ Cnn / RNRL in commercio dal:07/04/2021

PIQRAY 28 cpr riv 50 mg + 28 cpr riv 200 mg alpelisib
NOVARTIS AIC:048918054 7149,53€ Cnn / RNRL in commercio dal:07/04/2021

PIQRAY 56 cpr riv 150 mg alpelisib
NOVARTIS AIC:048918027 7149,53€ Cnn / RNRL in commercio dal:07/04/2021

REVESTIVE 28 flaconcini 1,25 mg + 28 siringhe preriempite solv teduglutide
TAKEDA AIC:045578034 12747,32€ H/RRL in commercio dal:06/04/2021

SUBOXONE 28 film sublinguali 2 mg + 0,5 mg buprenorfina cloridrato/naloxone cloridrato diidrato
INDIVIOR AIC:037604093 47,10€ Cnn / MMR in commercio dal:19/04/2021

SUBOXONE 28 film sublinguali 8 mg + 2 mg buprenorfina cloridrato/naloxone cloridrato diidrato
INDIVIOR AIC:037604156 188,39€ Cnn / MMR in commercio dal:19/04/2021

TRAZIMERA 1 flacone polv EV 420 mg trastuzumab
PFIZER AIC:046922023 2.136,69€ Cnn / RNRL in commercio dal:08/04/2021

VABOREM 6 flaconcini 1 g + 1 g polv meropenem triidrato/vaborbactam
MENARINI AIC:047422011 595,79€ H/OSP in commercio dal:06/04/2021

Nuovi farmaci equivalenti 
AMOXICILLINA E ACIDO CLAVULANICO ALMUS PHARMA 12 cpr riv 875 mg + 125 mg amoxicillina triidrato/potassio clavulanato
ALMUS AIC:046285019 7,90€ A/RR in commercio dal:02/04/2021

IRBESARTAN E IDROCLOROTIAZIDE PENSA 28 cpr 150 mg +12,5 mg irbesartan cloridrato/idroclorotiazide
PENSA PHARMA AIC:044893028 5,77€ A/RR in commercio dal:15/04/2021

LANSOPRAZOLO GIT 28 cps gastrores 15 mg lansoprazolo
S.F. GROUP AIC:037156080 6,72€ A/RR in commercio dal:07/04/2021

LINEZOLID AUROBINDO 10 sacche EV 300 ml 2 mg/ml linezolid
AUROBINDO AIC:045433036 624,44€ H/OSP in commercio dal:30/03/2021

METRONIDAZOLO AUROBINDO 20 cpr 250 mg metronidazolo
AUROBINDO AIC:048155016 2,32€ A/RR in commercio dal:07/04/2021

VENLAFAXINA SANDOZ 28 cps 150 mg rilascio prolungato venlafaxina cloridrato
SANDOZ AIC:045555075 18,41€ A/RR in commercio dal:06/04/2021

SEZIONE DOWNLOAD